Published:
Brennen Medical, LLC Launches XenMatriX(R) for Abdominal Wall (Hernia) Repair.
ST. PAUL, Minn., Oct. 8 /PRNewswire/ -- Brennen Medical, LLC a leader in
biomaterial technology announces the nationwide availability of its
XenMatriX(R) product for soft tissue reconstruction. Brennen Medical received
clearance to market XenMatriX(R), via the FDA 510k process, into the surgical
hernia market. Surgeons are successfully implanting XenMatriX in ventral
hernia/abdominal wall procedures, including complex repairs.
XenMatriX(R) is designed for use in the treatment of abdominal wall
(hernia) repair where the connective tissue has ruptured. With the aging
population and the obesity epidemic, over 30% of people over the age of 55
will seek treatment for soft tissue reinforcement. XenMatriX offers a
successful alternative to synthetic materials for this population in need of
surgical intervention.
XenMatriX(R) employs a patented technology that maintains an acellular,
structurally intact, non-crosslinked porcine dermal matrix for enhanced
biocompatibility in host tissue. This non-crosslinked dermal matrix supports
tissue revascularization, remodeling and regeneration for abdominal wall and
hernia repairs. The compatibility and strength of this material minimizes
hernia recurrence and pain, which also minimizes expense for both the patient
and the healthcare environment.
Phillip Lawin, President of Brennen Medical said, "We are extremely
pleased with the outcomes of XenMatriX. Unlike traditional mesh products,
XenMatriX(R) can be used successfully in contaminated or potentially
contaminated and complex fields. This provides patients and surgeons a truly
safe and effective alternative for abdominal wall hernia repair."
About Brennen Medical
Brennen Medical is a world leader providing biologic porcine xenograft for
use in plastic reconstructive, general surgical, burn, trauma, wound,
urogynecological and orthopedic soft tissue repair procedures. Demonstrated
to be effective, surgeons have used Brennen's proprietary porcine technologies
for over 40 years. Mediskin(TM)and EZ Derm(TM), XenMatriX(R), and
DermMatrix(R) provide the basis for innovation and quality to guide the
Company's initiatives for a growing biosurgical market. Based inSt. Paul, MN
and privately held, the products are sold through a direct sales force and
through partnerships with major medical device companies. In addition to
porcine, Brennen also markets a line of products containing beta glucan, a
natural complex carbohydrate providing improved wound healing and host tissue
regeneration. The company maintains a web site at http://www.brennenmed.com.
SOURCE Brennen Medical, LLC
Copyright © 2008, PRNewswire
Copyright © 2008, NewsBlaze,
Daily NewsTags: ,HEA,MTC,PDT,MN-Brennen-Medical
_ _Is your favorite bookmark site missing?
Ask for it.
Search News
Daily News
